Study of Rivoglitazone in Type 2 Diabetes Mellitus

Clinical trial NCT00484198 · COMPLETED

Trial details

NCT number: NCT00484198
Sponsor: Daiichi Sankyo
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2007-04-23
Primary completion: 2009-02-12
Enrollment: 1912

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.